Home
Professional Education
Conference Archives
Annual Conference on Vaccine Research
First Annual Conference on Vaccine Research (1998)

Conference Archives

First Annual Conference on Vaccine Research (1998)

Saturday, May 30, 1998

Welcome and Introductions
William J. Martone, MD
National Foundation for Infectious Diseases

Keynote Address

Promoting Vaccine Discovery: A Vision for the Future Robert F. Breiman, MD
Centers for Disease Control and Prevention

Symposium 1: Issues in Clinical and Field Trials: Design, Execution, and Analysis

Moderator:
Myron M. Levine, MD, DTPH
University of Maryland

Experimental Challenge Models to Test the Efficacy of Enteric, Respiratory, and Other Vaccines in Volunteers -- Rationale, Advantages, and Limitations
Carol O. Tacket, MD
University of Maryland School of Medicine

Evaluating the Performance of New Vaccines: Efficacy vs. Effectiveness
John D. Clemens, MD
National Institutes of Health

Challenges in HIV Vaccine Development: Institutional Roles and Response
Mary Lou Clements-Mann, MD
The Johns Hopkins University

Symposium 2: Correlates of Immunity: The Role of Surrogate Markers

Moderator:
David S. Krause, MD
SmithKline Beecham Pharmaceuticals

Introduction to Surrogate Markers
David S. Krause, MD
SmithKline Beecham Pharmaceuticals

Lessons from the Past
George R. Siber, MD
Wyeth-Lederle Vaccines and Pediatrics

A Regulatory Perspective
Karen Midthun, MD
U. S. Food and Drug Administration

Panel Discussion

Submitted Presentations 1

Symposium 3: Maternal Immunization as a Strategy to Protect Offspring

Moderator:
Pamela M. McInnes, DDS
National Institutes of Health

Maternal Immunization: Current Successes and Future Strategies
Pamela M. McInnes, DDS
National Institutes of Health

Immunological Aspects of Maternal Immunization
Richard A. Insel, MD
University of Rochester School of Medicine

Maternal Immunization: The Two for One Group B Streptococcal Prevention Model
Carol Baker, MD
Baylor College of Medicine

Maternal Immunization: Prevention of Respiratory Disease
W. Paul Glezen, MD
Baylor College of Medicine

Panel Discussion

Sunday, May 31, 1998

Symposium 4: Immunomodulators and Adjuvants

Moderator:
Frederick R. Vogel, PhD
National Institutes for Health

Overview of Immunomodulators and Adjuvants
Frederick R. Vogel, PhD
National Institutes for Health

Novel Adjuvants for Hepatitis B Protein and DNA Vaccines
Michael J. Caulfield, PhD
Merck Research Laboratories

Rational Design and Development of Adjuvant-Active Nonionic Block Copolymers
Mark J. Newman, PhD
Vaxcel, Inc.

Submitted Presentations 2

DNA IMMUNIZATION PROTECTS NONHUMAN PRIMATES AGAINST RABIES VIRUS - Donald 1. Lodmell
PROTECTIVE CTL RESPONSES AGAINST PARAMYXOVIRUSES INDUCED BY EPITOPE-BASED DNA VVACCINES - Shiou-chih Hsu
OPTIMIZING IMMUNE RESPONSES BY COEXPRESSION OF COSTIMULATORY MOLECUlES WITH A HEPATITIS B DNA VACCINE - Sowmya Balasubramanian
CONSTRUCTION OF A DNA VACCINE FOR TB CONTAINING PROMISCUOUS T CELL EPITOPES - I. Brichkov

Symposium 5: Combination Vaccine Strategies

Moderator:
Peter R. Paradiso, PhD
Wyeth-Lederle Vaccines and Pediatrics

Introduction to Combination Vaccines
Peter R. Paradiso, PhD
Wyeth-Lederle Vaccines and Pediatrics

Clinical Experience with Combination Vaccines
Scott A. Halperin, MD
Dalhousie University
IWK Grace Health Center

Immunological Considerations: Interference in Combination Vaccines
Steve Black, MD
Kaiser Permanente Vaccine Study Center

Panel Discussion

Submitted Presentations 3

Symposium 6: Mechanisms of Immune Evasion

Moderator:
Peter L. Nara, DVM, PhD
Biological Mimetics, Inc.
International Society for Vaccines

Introduction
Peter L. Nara, DVM, PhD
Biological Mimetics, Inc.
International Society for Vaccines

Molecular Mimicry in Murine Leishmaniasis
Nicolas Glaichenhaus, PhD
Université de Nice-Sophia Antipolis
Centre National de la Recherche Scientifique

Immunodominance and Immune Response to Tumor Antigens
Hans Schreiber, MD, PhD
University of Chicago

Effects of the First or Dominant Immune Response
Don A. Rowley, MD
University of Chicago

Immunodominance in the Protective Immune Repertoire to Influenza Infection
D.B. Thomas, DPhil
National Institute for Medical Research

Symposium 7: Effect of Age on the Immune Response

Moderator:
Richard J. Duma, MD, PhD
Halifax Medical Center

Immunology and Aging: An Overview James E. Nagel, MD
National Institutes of Health

Questions and Answers

Effect of Nutrition on Immunoresponsiveness in the Aged
Ranjit Kumar Chandra, MD
Memorial University of Newfoundland

Effect of Aging on Immune Response to Vaccines: Lessons in Animal Models
Bradley S. Bender, MD
University of Florida
Gainesville Veterans Affairs Medical Center

Monday, June 1, 1998

Symposium 8: Vaccine Delivery Technologies: Beyond Needle and Syringe

Moderator:
Bruce G. Weniger, MD
Centers for Disease Control and Prevention

Overview: The Challenge to Immunization Practice by Increasing Numbers of Parenteral Vaccines
Bruce G. Weniger, MD
Centers for Disease Control and Prevention

Mucosal Administration of Vaccine Antigens
Pearay L. Ogra, MD
Children's Hospital, University of Texas Medical Branch

Intranasal and Oral Delivery of Vaccines: Clinical Experience with Cold-Adapted Intranasal Influenza
Robert Belshe, MD
St. Louis University School of Medicine

Needle-Free Parenteral Jet Injection: Past, Present, and Future
Glenn Austin
Program for Appropriate Technology in Health (PATH)

Panel Discussion

Submitted Presentations 4

Symposium 9: Veterinary and Comparative Models of Disease and Protection

Moderator:
M.H.V. Van Regenmortel, PhD
Institut de Biologie Moleculaire et Cellulaire

Analysis of Protective Immunity in FIV
Margaret J. Hosie, PhD
University of Glasgow Veterinary School

Antigenic Mimicry in Foot and Mouth Disease M.H.V. Van Regenmortel, PhD
Institut de Biologie Moleculaire et Cellulaire

Nutritional Effects on Vaccination
Mark E. Cook, PhD
University of Wisconsin at Madison

Panel Discussion

Submitted Presentations 5

Poster Session A: Novel Vaccines and Novel Delivery Methods

Poster Session B: Assessing Immunologic Response and Disease Protection I

RESPONSE TO INFLUENZA VACCINE IN HIV-INFECTED INDIVIDUALS - F.A. Cruiekshank, MD
IMMUNOGENICITY OF FDA VERSUS WHO DTP - Mohamed Khalil, M.B. Beh, M.Se., MPH, MD
EFFECT OF ANNUAL INFLUENZA VACCINATION ON THE IMMUNOLOGlC RESPONSE IN THE ELDERLY - R. Ruttmann,
EFFECT OF PRIOR VACCINATION ON ANTIBODY RESPONSES TO INACTIVATED INFLUENZA VACCINE IN YEARS WHEN VACCINE COMPONENTS CHANGE AND IN YEARS WITHOUT A CHANGE IN VACCINE COMPONENTS - J. Treanor
EFFICACY AND EFFECTIVENESS OF INACTIVATED INFLUENZA VACCINE AMONG CHILDREN ATTENDING DAY CARE - Hurwitz, E.S.
NEONATAL GROUP B STREPTOCOCCAL DISEASE: PROGRESS TOWARD A MULTIVALENT MATERNAL VACCINE - L.C. Paoletti
SYSTEMIC IMMEDIATE-TYPE REACTIONS TO GELATIN INCLUDED IN VARICELLA AND JAPANESE ENCEPHALITIS (JE) VACCINES - Sakaguehi, M.

Conference Archives

First Annual Conference on Vaccine Research (1998)

Donate Now

Join

Subscribe

FEATURED PROGRAMS